There is a long and complicated tussle over patents in the pharma sector in India. Over the year, India has issued two compulsory licences for pharmaceuticals and made a number of other moves seen as hostile to patent holders (see this recent article on our sister site, Health Issues India)

Now, according to Business Line (part of the respected Hindu newspaper), India plans to do the same thing for wind and solar technology that it thinks it might need. Quite how India would justify this as part of its obligation under international agreements, remains to be seen

 

10711159_m